Reply to: Intensified Antithrombotic Regimens After the Initial Period of Double Antiplatelet Therapy: Are We Following the Evidence?

Am J Cardiol. 2023 Nov 15:207:292-293. doi: 10.1016/j.amjcard.2023.09.013. Epub 2023 Sep 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants
  • Clinical Protocols
  • Fibrinolytic Agents* / therapeutic use
  • Humans
  • Platelet Aggregation Inhibitors* / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Fibrinolytic Agents
  • Anticoagulants